company background image
AGEN

Agenus NasdaqCM:AGEN Stock Report

Last Price

US$2.56

Market Cap

US$780.3m

7D

-2.7%

1Y

-20.7%

Updated

06 Dec, 2022

Data

Company Financials +
AGEN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health1/6
Dividends0/6

AGEN Stock Overview

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally.

Agenus Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Agenus
Historical stock prices
Current Share PriceUS$2.56
52 Week HighUS$3.62
52 Week LowUS$1.25
Beta1.3
1 Month Change4.92%
3 Month Change0.79%
1 Year Change-20.74%
3 Year Change-35.19%
5 Year Change-24.04%
Change since IPO-99.30%

Recent News & Updates

Recent updates

Auditors Have Doubts About Agenus (NASDAQ:AGEN)

Mar 06
Auditors Have Doubts About Agenus (NASDAQ:AGEN)

Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts

Aug 11
Party Time: Brokers Just Made Major Increases To Their Agenus Inc. (NASDAQ:AGEN) Earnings Forecasts

Is Agenus Inc. (NASDAQ:AGEN) Popular Amongst Institutions?

Feb 15
Is Agenus Inc. (NASDAQ:AGEN) Popular Amongst Institutions?

What Type Of Returns Would Agenus'(NASDAQ:AGEN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Dec 24
What Type Of Returns Would Agenus'(NASDAQ:AGEN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Shareholder Returns

AGENUS BiotechsUS Market
7D-2.7%1.9%-0.4%
1Y-20.7%-11.2%-20.6%

Return vs Industry: AGEN underperformed the US Biotechs industry which returned -6.5% over the past year.

Return vs Market: AGEN underperformed the US Market which returned -17.6% over the past year.

Price Volatility

Is AGEN's price volatile compared to industry and market?
AGEN volatility
AGEN Average Weekly Movement13.8%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.3%

Stable Share Price: AGEN is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: AGEN's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1994441Garo Armenhttps://www.agenusbio.com

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant.

Agenus Inc. Fundamentals Summary

How do Agenus's earnings and revenue compare to its market cap?
AGEN fundamental statistics
Market CapUS$780.32m
Earnings (TTM)-US$214.70m
Revenue (TTM)US$89.90m

8.7x

P/S Ratio

-3.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
AGEN income statement (TTM)
RevenueUS$89.90m
Cost of RevenueUS$190.65m
Gross Profit-US$100.75m
Other ExpensesUS$113.95m
Earnings-US$214.70m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.70
Gross Margin-112.07%
Net Profit Margin-238.83%
Debt/Equity Ratio-113.7%

How did AGEN perform over the long term?

See historical performance and comparison